Real Life Cancer Comorbidity in Greek Patients with Diabetes Mellitus Followed Up at a Single Diabetes Center: An Unappreciated New Diabetes Complication
We determined cancer comorbidity in patients with diabetes followed up at a single Greek academic clinic and investigated the potential related factors. Cancer comorbidity was prospectively recorded for all patients with type 2 (T2DM, n=759) or type 1 (T1DM, n=134) diabetes of at least 10-year durat...
Saved in:
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2014-01-01
|
| Series: | Journal of Diabetes Research |
| Online Access: | http://dx.doi.org/10.1155/2014/231425 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1832562649380945920 |
|---|---|
| author | Anastasia Thanopoulou Demetrios Pectasides |
| author_facet | Anastasia Thanopoulou Demetrios Pectasides |
| author_sort | Anastasia Thanopoulou |
| collection | DOAJ |
| description | We determined cancer comorbidity in patients with diabetes followed up at a single Greek academic clinic and investigated the potential related factors. Cancer comorbidity was prospectively recorded for all patients with type 2 (T2DM, n=759) or type 1 (T1DM, n=134) diabetes of at least 10-year duration examined during one year. Patient characteristics, diabetes age of onset, duration, treatment, control, and complication rates were compared between subjects with and without cancer. Moreover, a retrospective collection of data from similar patients examined for the first time during the last 25 years, but lost to follow-up, after at least one-year’s regular visits, was performed. In regularly followed-up T2DM patients cancer comorbidity was 12.6%. Patients with cancer were older and more frequently smokers. Prostate cancer was the most frequent (24.0%) type. In T1DM cancer comorbidity was 3.0%. Similar rates of comorbidity and types of cancer were observed in lost to follow-up patients. In conclusion, our patients with T2DM of at least 10-year’ duration show high cancer comorbidity. No specific characteristics discriminate patients with cancer. Therefore presymptomatic cancer detection and prevention strategies may have to be incorporated into the annual systematic evaluation of our patients. |
| format | Article |
| id | doaj-art-0331ac21c5444713bb2135041ba01eaa |
| institution | Kabale University |
| issn | 2314-6745 2314-6753 |
| language | English |
| publishDate | 2014-01-01 |
| publisher | Wiley |
| record_format | Article |
| series | Journal of Diabetes Research |
| spelling | doaj-art-0331ac21c5444713bb2135041ba01eaa2025-02-03T01:22:00ZengWileyJournal of Diabetes Research2314-67452314-67532014-01-01201410.1155/2014/231425231425Real Life Cancer Comorbidity in Greek Patients with Diabetes Mellitus Followed Up at a Single Diabetes Center: An Unappreciated New Diabetes ComplicationAnastasia Thanopoulou0Demetrios Pectasides1Diabetes Centre, 2nd Department of Internal Medicine, National University of Athens, Hippokration General Hospital, 114 Vassilissis Sofias Avenue, 115 27 Athens, GreeceDiabetes Centre, 2nd Department of Internal Medicine, National University of Athens, Hippokration General Hospital, 114 Vassilissis Sofias Avenue, 115 27 Athens, GreeceWe determined cancer comorbidity in patients with diabetes followed up at a single Greek academic clinic and investigated the potential related factors. Cancer comorbidity was prospectively recorded for all patients with type 2 (T2DM, n=759) or type 1 (T1DM, n=134) diabetes of at least 10-year duration examined during one year. Patient characteristics, diabetes age of onset, duration, treatment, control, and complication rates were compared between subjects with and without cancer. Moreover, a retrospective collection of data from similar patients examined for the first time during the last 25 years, but lost to follow-up, after at least one-year’s regular visits, was performed. In regularly followed-up T2DM patients cancer comorbidity was 12.6%. Patients with cancer were older and more frequently smokers. Prostate cancer was the most frequent (24.0%) type. In T1DM cancer comorbidity was 3.0%. Similar rates of comorbidity and types of cancer were observed in lost to follow-up patients. In conclusion, our patients with T2DM of at least 10-year’ duration show high cancer comorbidity. No specific characteristics discriminate patients with cancer. Therefore presymptomatic cancer detection and prevention strategies may have to be incorporated into the annual systematic evaluation of our patients.http://dx.doi.org/10.1155/2014/231425 |
| spellingShingle | Anastasia Thanopoulou Demetrios Pectasides Real Life Cancer Comorbidity in Greek Patients with Diabetes Mellitus Followed Up at a Single Diabetes Center: An Unappreciated New Diabetes Complication Journal of Diabetes Research |
| title | Real Life Cancer Comorbidity in Greek Patients with Diabetes Mellitus Followed Up at a Single Diabetes Center: An Unappreciated New Diabetes Complication |
| title_full | Real Life Cancer Comorbidity in Greek Patients with Diabetes Mellitus Followed Up at a Single Diabetes Center: An Unappreciated New Diabetes Complication |
| title_fullStr | Real Life Cancer Comorbidity in Greek Patients with Diabetes Mellitus Followed Up at a Single Diabetes Center: An Unappreciated New Diabetes Complication |
| title_full_unstemmed | Real Life Cancer Comorbidity in Greek Patients with Diabetes Mellitus Followed Up at a Single Diabetes Center: An Unappreciated New Diabetes Complication |
| title_short | Real Life Cancer Comorbidity in Greek Patients with Diabetes Mellitus Followed Up at a Single Diabetes Center: An Unappreciated New Diabetes Complication |
| title_sort | real life cancer comorbidity in greek patients with diabetes mellitus followed up at a single diabetes center an unappreciated new diabetes complication |
| url | http://dx.doi.org/10.1155/2014/231425 |
| work_keys_str_mv | AT anastasiathanopoulou reallifecancercomorbidityingreekpatientswithdiabetesmellitusfollowedupatasinglediabetescenteranunappreciatednewdiabetescomplication AT demetriospectasides reallifecancercomorbidityingreekpatientswithdiabetesmellitusfollowedupatasinglediabetescenteranunappreciatednewdiabetescomplication |